Keros Therapeutics (KROS) Profit After Tax (QoQ) (2019 - 2025)
Keros Therapeutics (KROS) Profit After Tax (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Keros Therapeutics | 383.01 Mn | 95.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -222.27% |
| Sep 30, 2025 | 76.28% |
| Jun 30, 2025 | -120.68% |
| Mar 31, 2025 | 422.54% |
| Dec 31, 2024 | 13.09% |
| Sep 30, 2024 | -17.01% |
| Jun 30, 2024 | -4.97% |
| Mar 31, 2024 | -7.13% |
| Dec 31, 2023 | -2.04% |
| Sep 30, 2023 | -5.16% |
| Jun 30, 2023 | -4.75% |
| Mar 31, 2023 | -20.48% |
| Dec 31, 2022 | -26.41% |
| Sep 30, 2022 | 13.78% |
| Jun 30, 2022 | -12.73% |
| Mar 31, 2022 | -248.50% |
| Dec 31, 2021 | 65.81% |
| Sep 30, 2021 | -29.93% |
| Jun 30, 2021 | 1.66% |
| Mar 31, 2021 | -48.79% |